Abaxis, Inc. (NASDAQ:ABAX)

CAPS Rating: 3 out of 5

The Company develops, manufactures and markets portable blood analysis systems for use in any veterinary or human patient-care setting to provide clinicians with rapid blood constituent measurements.


Player Avatar brent2112 (< 20) Submitted: 1/12/2007 12:44:23 PM : Underperform Start Price: $18.87 ABAX Score: -117.38

Abaxis has seen its glory days. I've watched this stock climb from $4-5 per share up to over $20. Unless they come up with something new, they will be relying on their reagent discs to supply income.

Featured Broker Partners